Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).

@article{TatuChioiu2004AcceleratedSA,
  title={Accelerated streptokinase and enoxaparin in ST-segment elevation acute myocardial infarction (the ASENOX study).},
  author={Gabriel Tatu-Chiţoiu and C. Teodorescu and Petre Căpraru and Manuela Guran and Oana Istrăţescu and Monica Dan and Alexandrina Tatu-Chiţoiu and Aurelia Bumbu and Valentin Chioncel and Maria I Dorobantu},
  journal={Kardiologia polska},
  year={2004},
  volume={60 5},
  pages={441-6}
}
BACKGROUND The streptokinase (SK) regimen (1.5 MU/60 min) has remained unchanged in the ST-segment elevation acute myocardial infarction (STEMI) for the last 20 years. AIM To compare the efficacy of an accelerated SK (ASK) regimen combined with enoxaparin (Enox) or heparin (UFH) with the standard SK and UFH combination in STEMI. METHODS 633 consecutive patients, aged 21-74 years, admitted within 6 hours after the onset of STEMI, were divided in three groups: (1) ASKEnox (n=165): Enox 40 mg… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS